newdrugapprovals.org
US priority review for Eisai cancer drug lenvatinib
US priority review for Eisai cancer drug lenvatinib Eisai has been boosted by news that regulators in the USA have agreed to a quicker review of its anticancer agent lenvatinib. The US Food and Dru…